A novel oral prodrug-targeting transporter MCT 1: 5-fluorouracil-dicarboxylate monoester conjugates
Monocarboxylate transporter 1 (MCT1) is responsible for oral absorption of short-chain monocarboxylic acids from small intestine, hence, it's likely to serve as an ideal design target for the development of oral prodrugs. However, potential application of MCT1 to facilitate the oral delivery is...
Main Authors: | Yixin Sun, Dongyang Zhao, Gang Wang, Qikun Jiang, Mengran Guo, Qiming Kan, Zhonggui He, Jin Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-11-01
|
Series: | Asian Journal of Pharmaceutical Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087618313849 |
Similar Items
-
Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability
by: Gang Wang, et al.
Published: (2020-03-01) -
The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs
by: Yasuhiro Tsume, et al.
Published: (2014-01-01) -
Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine
by: Yasuhiro Tsume, et al.
Published: (2017-08-01) -
Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
by: Jincheng Yang, et al.
Published: (2018-01-01) -
Enhanced Absorption and Growth Inhibition with Amino Acid Monoester Prodrugs of Floxuridine by Targeting hPEPT1 Transporters
by: Gordon L. Amidon, et al.
Published: (2008-06-01)